The present invention provides a mushroom-containing Chinese medicine compound composition for treating keloid scar tissue, the composition including: brown strain of Flammulina velutipes extract, Artemisinin, Matrine, Triptolide, Tetramethylpyrazine, Tetrandrine, Curcumin, Resveratrol, EGCG, Quercetin and Asiaticoside. Said mushroom-containing Chinese medicine compound composition is used to inhibit the proliferation of keloid fibroblast, and to treat, inhibit or reduce the symptoms of keloid fibroblast.

The present invention relates to an antioxidant composition containing an extracellular polysaccharide produced using Ceriporia lacerata, or a mycelium culture of Ceriporia lacerata comprising the same, or a dry powder or an extract thereof as an active ingredient. The composition can be used as an antioxidant for preventing or treating various diseases such as brain diseases such as stroke, Parkinson's disease, etc., heart diseases, ischemia, arteriosclerosis, skin damage, inflammation, rheumatism, autoimmune diseases, etc. including cancers as well as aging, or as a health functional food, a cosmetic material or a feed composition having an antioxidant effect.

The present invention relates to an antioxidant composition containing an extracellular polysaccharide produced using Ceriporia lacerata, or a mycelium culture of Ceriporia lacerata comprising the same, or a dry powder or an extract thereof as an active ingredient. The composition can be used as an antioxidant for preventing or treating various diseases such as brain diseases such as stroke, Parkinson's disease, etc., heart diseases, ischemia, arteriosclerosis, skin damage, inflammation, rheumatism, autoimmune diseases, etc. including cancers as well as aging, or as a health functional food, a cosmetic material or a feed composition having an antioxidant effect.

The invention is a method for enhanced growth of mycelium in culture including the key steps of seed blend choice from among corn, rice, quinoa, chia, canihua, cumin and flax seed, germinating the seed blend prior to inoculating the mycelium starter, and conducting the mushroom cultivation with water and particular transmissions of sound and particularly colored light. Mushrooms grown by such a method not only mature in 13-15 days rather than 21 days, but have an enhanced nutritional and medicinal profile along with absence of unwanted organism contaminants whose unwanted overgrowth occurs during days 16-21 (or days 16-28) of typical mushroom culture.

The invention is a method for enhanced growth of mycelium in culture including the key steps of seed blend choice from among corn, rice, quinoa, chia, canihua, cumin and flax seed, germinating the seed blend prior to inoculating the mycelium starter, and conducting the mushroom cultivation with water and particular transmissions of sound and particularly colored light. Mushrooms grown by such a method not only mature in 13-15 days rather than 21 days, but have an enhanced nutritional and medicinal profile along with absence of unwanted organism contaminants whose unwanted overgrowth occurs during days 16-21 (or days 16-28) of typical mushroom culture.

Provided is a method for preventing or treating cancer in a subject in need thereof, including administering to the subject an effective amount of a composition including a fraction of polysaccharide isolated from Antrodia cinnamomea cultured in the presence of zinc sulfate and a carrier thereof, wherein the polysaccharide includes glucose and fucose. Also provided are a method for preparing the composition and a composition including the polysaccharide fraction obtained therefrom.

Provided is a method for preventing or treating cancer in a subject in need thereof, including administering to the subject an effective amount of a composition including a fraction of polysaccharide isolated from Antrodia cinnamomea cultured in the presence of zinc sulfate and a carrier thereof, wherein the polysaccharide includes glucose and fucose. Also provided are a method for preparing the composition and a composition including the polysaccharide fraction obtained therefrom.

The liquid composition includes a psychoactive alkaloid extract or synthetic psychoactive alkaloid. The alkaloids in the extract are predominantly dephosphorylated rather than phosphorylated. The injectable psychoactive alkaloid composition includes a carrier, an optional tonicity modifier, an optional antioxidant or preservative, an optional pH modifier, and optional further excipients. A process for obtaining an injectable psychoactive alkaloid composition includes dephosphorylating the alkaloid during extraction, purifying the extracted alkaloid, and standardizing it to a specific concentration by adding measured quantities of excipients.

The present invention “use of Maitake and Maitake polysaccharide D Fraction in manufacture of medicaments for anti-depression” belongs to the field of pharmaceuticals, which characterized in that the Maitake whole herb, Maitake extract or Maitake polysaccharide D fraction is used in the preparation of antidepressants. The medicament can be used to treat or prevent depression, which has a significant antidepressant effect, not only strong effect, but also no conventional antidepressant medicaments toxicity, side effects, such as induced epilepsy, ataxia and other shortcomings. Therefore, they can be used as an excellent antidepressant candidate medicament.

The present invention “use of Maitake and Maitake polysaccharide D Fraction in manufacture of medicaments for anti-depression” belongs to the field of pharmaceuticals, which characterized in that the Maitake whole herb, Maitake extract or Maitake polysaccharide D fraction is used in the preparation of antidepressants. The medicament can be used to treat or prevent depression, which has a significant antidepressant effect, not only strong effect, but also no conventional antidepressant medicaments toxicity, side effects, such as induced epilepsy, ataxia and other shortcomings. Therefore, they can be used as an excellent antidepressant candidate medicament.